NLS COVID-19

COVID-19 - February 7, 2022

COVID-19 vaccine-induced protection wanes at different speed

The vaccine-induced protection against SARS-CoV-2 infection wanes within a couple of months, but at different speed according to vaccine type, reports scientists from Umeå University. However, protection against severe COVID-19 appears to be better maintained. This is shown in a nationwide, registry-based study performed by researchers at Umeå University that now is published in The […]

COVID-19 - January 31, 2022

BerGenBio’s bemcentinib will be studied in the EU-SolidAct trial

BerGenBio and Oslo University Hospital have announced the execution of a collaborative agreement to study the BerGenBio AXL inhibitor bemcentinib, in hospitalised COVID-19 patients. The EU-SolidAct trial – European DisCoVeRy for Solidarity: An Adaptive Pandemic and Emerging Infection Platform Trial – is part of EU-RESPONSE, a pan-European research project involved with the rapid and coordinated […]

COVID-19 - January 19, 2022

Research shows persistent T cell response to omicron after infection and vaccination

A new study from Karolinska Institutet shows that T cells still recognize omicron after infection with previous variants of SARS-CoV-2 or vaccination. The omicron variant can partly evade the antibody response provided by vaccination or infection with previous variants of SARS-CoV-2. However, T cells still recognize omicron, the scientists report in a study published in […]

COVID-19 - January 19, 2022

COVID-19 smell and taste loss may have genetic link

Scientists have identified some genetic variants in people that may more likely lose their ability to taste and smell. The study, published in Nature Genetics, investigated nearly 70,000 adults with COVID-19 and found that persons with certain genetic tweaks on chromosome 4 were 11 percent more likely to lose the ability to smell and taste […]

COVID-19 - January 19, 2022

First subject dosed with Nykode’s vaccine candidate

Nykode Therapeutics has announced that the first subject has been dosed with its T cell focused next-generation SARS-CoV-2 vaccine candidate in its VB-D-01 Phase 1/2 trial. The T cell specific vaccine is designed to prime T cells, potentially generating a broad immune response against current and future variants. The VB-D-01 trial is a two-arm, open […]

COVID-19 - January 14, 2022

Protective gene variant against COVID-19 discovered

An international metastudy led by researchers at Karolinska Institutet has identified a specific gene variant that protects against severe COVID-19 infection. The researchers managed to pinpoint the variant by studying people of different ancestries, a feat they say highlights the importance of conducting clinical trials that include people of diverse descents. The results are published […]

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.